immunotherapy
Treatment for Cluster Headache
Immunotherapy for Cluster Headache involves the use of monoclonal antibodies targeting calcitonin gene-related peptide (CGRP) or its receptor, which modulate inflammatory pain pathways and neurogenic inflammation. These targeted therapies work by blocking CGRP signaling, thereby reducing the frequency, intensity, and duration of cluster headache attacks by interrupting neurogenic inflammatory processes and pain signal transmission.